Tag Archives: CF3 derivative of Tazarotene

Design of novel tazarotene derivatives as potential antipsoriatic drugs   What is Psoriasis? Psoriasis is a prevalent chronic inflammatory skin condition afflicting about 2-4% of patients all over the world. Psoriasis is mostly characterized by the skin covered with red, well-defined, hardened plaques with silver and micaceous scale. Complications associated …

Read More »